Results for tag: "Pritor"

The Pritor market is a segment of the cardiovascular drug market that focuses on the treatment of hypertension. It is composed of drugs that contain the active ingredient telmisartan, which is an angiotensin receptor blocker (ARB). These drugs are used to reduce high blood pressure and can be used alone or in combination with other medications. They are generally well-tolerated and have few side effects. The Pritor market is highly competitive, with many companies offering their own branded versions of the drug. Some of the major players in the market include Boehringer Ingelheim, Novartis, Sanofi, and AstraZeneca. Other companies such as Mylan, Lupin, and Sun Pharmaceuticals also offer generic versions of the drug. Show Less Read more